Hashimoto Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who meet all of the following conditions will be considered for enrollment: 1. Females, aged between 20 and 45 years; 2. Patients with Hashimoto's thyroiditis with normal thyroid function(TSH < 5.0 mIU/L) ; 3. Patients trying to conceive; 4. Patients willing to participate in the study and sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with infertility caused by diseases of reproductive system organs or male infertility; 2. Patients with bleeding disorder (such as thrombocytopenia and coagulation disorder with bleeding tendency); 3. Patients with mental illness (severe anxiety and depression, schizophrenia); 4. Patients with malignant tumors and serious organic diseases; 5. Patients with a history of thyroid radioiodine therapy or surgical intervention; 6. Patients who use immunosuppressants, immunostimulants or drugs (such as corticosteroids, lithium and amiodarone) that interfere with the production, transport and metabolism of thyroid hormones; 7. Patients with pacemaker, metal allergy or artificial joint; 8. Patients who participated in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TPOAb; | — |
Secondary
| Measure | Time frame |
|---|---|
| TGAb, fT4, fT3, thyroxine, TSH;pregnancy rate(%), pregnancy losses (%), and live birth rate (%);primary ovarian insufficiency (%);AMH, FSH, LH, E2; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine